Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Highly Active Antiretroviral Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01240486
What this trial is testing

IMPAACT P1073: Study of IRIS for Infants and Children Initiating HAART at Int'l Sites

Who this might be right for
IRISHIV
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 207
Post-approval studies (Phase 4)Study completedNCT02431975
What this trial is testing

Latency and Early Neonatal Provision of Antiretroviral Drugs Clinical Trial

Who this might be right for
HIV
Columbia University 73
Testing effectiveness (Phase 2)Ended earlyNCT00196651
What this trial is testing

HIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides in Patients Treated Early With HAART During Primary Infection

Who this might be right for
HIV Infection
French National Agency for Research on AIDS and Viral Hepatitis 60
Early research (Phase 1)Study completedNCT00117429
What this trial is testing

Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infections
Marcus Altfeld, M.D., Ph.D. 20
Large-scale testing (Phase 3)Study completedNCT00408642
What this trial is testing

An Enhanced Adherence Support Programme for Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infections
Centre for the AIDS Programme of Research in South Africa 297
Testing effectiveness (Phase 2)Study completedNCT00647946
What this trial is testing

Study to Evaluate Changes in Limb Fat When Switching From a Thymidine Analogue

Who this might be right for
Lipodystrophy
Gilead Sciences 100
Not applicableStudy completedNCT00463086
What this trial is testing

Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons

Who this might be right for
TuberculosisLatent Tuberculosis InfectionHIV Infections
University of Cape Town 1,368
Testing effectiveness (Phase 2)Study completedNCT00031070
What this trial is testing

Increasing HAART-Induced Immune Restoration With Cyclosporine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Testing effectiveness (Phase 2)Study completedNCT00518154
What this trial is testing

Pilot Study of Pyridostigmine Upon Immune Activation in HIV-1 Patients Who Have an Inadequate Immune Response

Who this might be right for
HIV Infections
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 7
Testing effectiveness (Phase 2)Study completedNCT00672191
What this trial is testing

Phase II Study of AGS-004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV

Who this might be right for
HIV Infections
Argos Therapeutics 59
Testing effectiveness (Phase 2)WithdrawnNCT01515813
What this trial is testing

Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Post-approval studies (Phase 4)Study completedNCT03838497
What this trial is testing

Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine Among HIV-infected Adults

Who this might be right for
Streptococcal PneumoniaHIV/AIDS
Korea University Guro Hospital 70
Not applicableStudy completedNCT01044810
What this trial is testing

Effectiveness of Efavirenz-based Regimen in HIV-1-infected Patients With Nevirapine Hypersensitivity

Who this might be right for
Treatment Failure, HIV or AIDSCD4 Cell Counts
Bamrasnaradura Infectious Diseases Institute 559
Not applicableNot Yet RecruitingNCT07219862
What this trial is testing

Evaluating a Clinical Decision Support Tool for Antiretroviral Therapy Optimization

Who this might be right for
HIV (Human Immunodeficiency Virus)Clinical Decision Support System (CDSS)Antiretroviral Therapy, Highly Active+4 more
Keck School of Medicine of USC 250
Large-scale testing (Phase 3)Study completedNCT00028327
What this trial is testing

Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive Care

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 250
Not applicableStudy completedNCT00001948
What this trial is testing

Health-Related Quality of Life in HIV-Infected Patients Undergoing Structured Treatment Interruptions of Highly Active Antiretroviral Therapy

Who this might be right for
HIV Infection
National Institutes of Health Clinical Center (CC) 70
Early research (Phase 1)Study completedNCT00107549
What this trial is testing

Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Testing effectiveness (Phase 2)Study completedNCT00710593
What this trial is testing

Impact of a Human Papilloma Virus (HPV) Vaccine in HIV-Infected Young Women

Who this might be right for
HIV Infection
University of North Carolina, Chapel Hill 99
Post-approval studies (Phase 4)Study completedNCT00979706
What this trial is testing

Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection (PHI-IMD).

Who this might be right for
HIV
Juan A. Arnaiz 22
Not applicableStudy completedNCT00004735
What this trial is testing

The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 81
Next Page